Sensitive molecular assays have greatly improved the diagnosis of viral gastroenteritis. However, the proper preparation of stool samples for clinical testing remains an issue. bioMérieux has developed a stool preprocessing device (SPD) that includes a spoon for calibrated sampling and a vial containing buffer, glass beads, and two filters. The resulting stool filtrate is used for nucleic acid extraction. The purpose of this study was to evaluate the performance of the SPD for the quantification of human adenovirus (HAdV) DNA in stool samples collected from hematopoietic stem cell transplant (HSCT) recipients. HAdV DNA was quantified with the Adenovirus R-gene kit. The suitability of the device to reproducibly quantify HAdV DNA in stools using different extraction platforms (easyMAG and QIAsymphony) was determined using archived HAdV-positive stool samples. Coefficients of variation of HAdV DNA quantifications ranged from 1.79% to 1.83%, and no difference in quantification was observed between the two extraction systems. The HAdV DNA limit of quantification using the SPD was 3.75 log 10 copies/g of stool. HAdV DNA quantification using the SPD was then compared to that of the routine preprocessing technique on 75 fresh stool samples collected prospectively from pediatric HSCT recipients at risk for HAdV infections. Thirty-eight samples were HAdV DNA positive with both the SPD and routine preprocessing methods. HAdV DNA loads were on average 1.14-log 10 copies/g of stool higher with the SPD (P < 0.0001) than with routine methods. This new device enabled a standardized preparation of stool samples in <5 min and a reproducible and sensitive quantification of HAdV DNA. The use of the SPD for the detection of other gastrointestinal infections warrants further evaluation.
PCR is a very rapid and reliable tool for molecular biologybased diagnosis of a variety of infectious diseases, using a wide range of clinical sample types (1).However, stool samples are among the most difficult clinical samples to process for molecular pathogen detection because of the presence of very potent inhibitors of nucleic acid (NA) amplification that are often coextracted along with pathogen NAs (2-4). Bile salts, hemoglobin, polysaccharides, heme, and bilirubin have been identified as factors that inhibit amplification assays (3, 5-8). Inhibitory effects can be reduced by adding amplification facilitators, such as bovine serum albumin, to the PCR mixture (9) by using thermostable polymerases that are more resistant to PCR inhibition (10), or by using more efficient processes for extracting NAs from stool samples (11). The efficiency of NA extraction and purification has been shown to influence the sensitivity, reproducibility, and accuracy of NA amplification-based target detection (12).Due to the potential presence of amplification inhibitors, sample preprocessing before NA extraction is an essential step to improve amplification-based pathogen detection from stool samples. Currently, stool preparation is not standardized and can be labor-...